Cornelis J A Punt

Clinical Usefulness of Tools to Support Decision‐making for Palliative Treatment of Metastatic Colorectal Cancer: A Systematic Review

Dóra Révész, Ewout W Steyerberg, Henrica C W De Vet, 2017, Clinical colorectal cancer.

In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength.

Dennis W J Klomp, Arend Heerschap, A. Heerschap, 2003, Cancer research.

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

Arend Heerschap, Tom W J Scheenen, Jeff W M Bulte, 2005, Nature Biotechnology.

MicroRNAs in colorectal cancer metastasis

I. Nagtegaal, C. Punt, L. Mekenkamp, 2011, The Journal of pathology.

Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use?

Arend Heerschap, W. Oyen, L. de Geus-Oei, 2012, Critical reviews in oncology/hematology.

Evidence‐based medicine: the time has come to set standards for staging

Vincenzo Valentini, Bengt Glimelius, I. Nagtegaal, 2010, The Journal of pathology.

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.

Linda Mol, Miriam Koopman, O. Dalesio, 2009, The New England journal of medicine.

Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review.

C. Punt, J. Tol, Cornelis J A Punt, 2010, Clinical therapeutics.

Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database.

Daniel J Sargent, Christophe Tournigand, Eduardo Diaz-Rubio, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

Marc Peeters, Hua Yu, Gregory Wilson, 2015, Clinical Cancer Research.

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

Michael Morse, Nicholas Iannotti, Neal J Meropol, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.

C. Figdor, C. Punt, G. Adema, 2008, Blood.